Platelet-activating factor (PAF) receptor antagonist (Ki
= 1.3 μ
M). Inhibits neutrophil degranulation and superoxide production in vitro
and inhibits bronchoconstriction and is neuroprotective following oral administration in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Foldes-Filep et al.
Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand et al.
The CNS effects of Ginkgo biloba extracts and ginkgolide B.
Maclennan et al.
The citations listed below are publications that use Tocris products. Selected citations for Ginkgolide B include:
Showing Results 1 - 1 of 1